Mathes Company’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Mathes Company’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$549K	Hold	3,470	–	–	0.17%	86
2026 Q1	$443K	Hold	3,470	–	–	0.16%	86
2025 Q4	$423K	Hold	3,470	–	–	0.15%	91
2025 Q3	$348K	Sell	3,470 -1,300	-27%	-$117K	0.12%	104
2025 Q2	$396K	Sell	4,770 -1,775	-27%	-$142K	0.15%	94
2025 Q1	$531K	Sell	6,545 -1,100	-14%	-$98.3K	0.22%	81
2024 Q4	$689K	Sell	7,645 -1,470	-16%	-$142K	0.25%	71
2024 Q3	$901K	Sell	9,115 -325	-3%	-$31.9K	0.32%	65
2024 Q2	$875K	Sell	9,440 -1,275	-12%	-$114K	0.32%	65
2024 Q1	$1.02M	Buy	10,715 +5,050	+89%	+$469K	0.38%	62
2023 Q4	$506K	Hold	5,665	–	–	0.21%	87
2023 Q3	$414K	Hold	5,665	–	–	0.19%	91
2023 Q2	$471K	Buy	+5,665	New	+$474K	0.21%	92
2022 Q4	$470K	Sell	5,665 -1,350	-19%	-$109K	0.24%	87
2022 Q3	$556K	Sell	7,015 -6,825	-49%	-$575K	0.31%	76
2022 Q2	$1.03M	Buy	13,840 +2,520	+22%	+$189K	0.5%	58
2022 Q1	$1.02M	Buy	11,320 +4,750	+72%	+$439K	0.39%	66
2021 Q4	$736K	Buy	+6,570	New	+$792K	0.25%	81
2021 Q3	–	Sell	-6,495	Closed	-$879K	–	125
2021 Q2	$879K	Buy	6,495 +1,585	+32%	+$208K	0.32%	75
2021 Q1	$666K	Buy	4,910 +500	+11%	+$74.9K	0.26%	82
2020 Q4	$621K	Sell	4,410 -205	-4%	-$26.3K	0.25%	84
2020 Q3	$514K	Buy	+4,615	New	+$517K	0.24%	83

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Mathes Company's XBI Position: Q2 2026 in Review

Mathes Company held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q2 2026 at 3,470 shares worth $549K. The position accounts for 0.17% of the portfolio, ranked #86.

Mathes Company first reported a position in XBI in Q3 2020 and has held it in 22 quarters since. The position peaked at $1.03M in Q2 2022. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Mathes Company held 3,470 shares of State Street SPDR S&P Biotech ETF worth $549K as of Q2 2026.
Mathes Company left its State Street SPDR S&P Biotech ETF share count unchanged in Q2 2026.
State Street SPDR S&P Biotech ETF made up 0.17% of Mathes Company's portfolio in Q2 2026, its #86 holding.
Mathes Company first reported a position in State Street SPDR S&P Biotech ETF in Q3 2020 and has held it in 22 quarters since.
Mathes Company's State Street SPDR S&P Biotech ETF position peaked at $1.03M in Q2 2022.
933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Mathes Company's 13F filing for Q2 2026, filed 11 Aug 2026.